المؤلفون: Morral C; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Ayyaz A; Centre for Systems Biology, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada.; Department of Biological Sciences, University of Calgary, Calgary, AB, Canada., Kuo HC; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Fink M; Centre for Systems Biology, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada., Verginadis II; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Daniel AR; Department of Radiation Oncology, Duke University, Durham, NC, USA., Burner DN; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Driver LM; Department of Radiation Oncology, Duke University, Durham, NC, USA.; Department of Pathology, Duke University, Durham, NC, USA., Satow S; Department of Radiation Oncology, Duke University, Durham, NC, USA., Hasapis S; Department of Radiation Oncology, Duke University, Durham, NC, USA., Ghinnagow R; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Luo L; Department of Radiation Oncology, Duke University, Durham, NC, USA., Ma Y; Department of Radiation Oncology, Duke University, Durham, NC, USA., Attardi LD; Departments of Radiation Oncology and Genetics, Stanford University, Palo Alto, CA, USA., Koumenis C; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Minn AJ; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Mark Foundation Center for Immunotherapy, Immune Signaling, and Radiation, University of Pennsylvania, Philadelphia, PA, USA., Wrana JL; Centre for Systems Biology, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada. wrana@lunenfeld.ca.; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada. wrana@lunenfeld.ca., Lee CL; Department of Radiation Oncology, Duke University, Durham, NC, USA. chang-lung.lee@duke.edu.; Department of Pathology, Duke University, Durham, NC, USA. chang-lung.lee@duke.edu., Kirsch DG; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA. david.kirsch@uhn.ca.; Department of Radiation Oncology, Duke University, Durham, NC, USA. david.kirsch@uhn.ca.; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. david.kirsch@uhn.ca.; Departments of Radiation Oncology and Medical Biophysics, University of Toronto, Toronto, ON, Canada. david.kirsch@uhn.ca.

المصدر: Nature communications [Nat Commun] 2024 Apr 08; Vol. 15 (1), pp. 3018. Date of Electronic Publication: 2024 Apr 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Tumor Suppressor Protein p53*/genetics , Tumor Suppressor Protein p53*/metabolism , Radiation Injuries*/genetics , Radiation Injuries*/metabolism, Mice ; Animals ; Intestines ; Gastrointestinal Tract/metabolism ; Stem Cells/metabolism ; Apoptosis/genetics